- Xylem Inc (NYSE:XYL) disclosed the acquisition closure of Evoqua Water Technologies Corp (NYSE:AQUA) in an all-stock transaction for around $7.5 billion.
- The deal boosts Xylem’s leadership in water technologies solutions and services business and creates a highly advanced global platform for addressing critical water challenges.
- As per the terms, Evoqua shareholders will receive 0.48 shares of Xylem for each Evoqua share, representing a value of $52.89 per share or a 29% premium based on Xylem and Evoqua closing prices as of January 20, 2023.
- After closure, Xylem shareholders will own around 75% of the combined company, while Evoqua will own the rest.
- “Our combination with Evoqua creates a transformative global platform to solve these critical water challenges at an even greater scale. Together, we are uniquely positioned to help meet customers’ mission-critical needs with an unmatched portfolio of products and services across the water cycle,” said Patrick Decker, President and CEO.
- Earlier this month, XYL reported Q1 2023 revenues of $1.45 billion, beating the consensus of $1.34 billion, and adjusted EPS of $0.72 exceeded the consensus of $0.62.
- Price Action: XYL shares are trading lower by 2.05% at $102.01 on the last check Wednesday.
Emergent Plans $50 Price Point For Narcan OTC Version For Opioid Overdose Reversal
Emergent BioSolutions Inc (NYSE: EBS) looks to price its over-the-counter (OTC) version of its opioid overdose reversal Narcan at around $50 per carton of two 4 mg doses.
